C
Cees G. M. Kallenberg
Researcher at University of Groningen
Publications - 99
Citations - 17225
Cees G. M. Kallenberg is an academic researcher from University of Groningen. The author has contributed to research in topics: Anti-neutrophil cytoplasmic antibody & Vasculitis. The author has an hindex of 48, co-authored 94 publications receiving 15135 citations. Previous affiliations of Cees G. M. Kallenberg include University Medical Center Groningen.
Papers
More filters
Journal ArticleDOI
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
John Charles Jennette,Ronald Falk,P. A. Bacon,Neil Basu,Maria C. Cid,Franco Ferrario,Luis Felipe Flores-Suárez,W. L. Gross,Loïc Guillevin,E. C. Hagen,Gary S. Hoffman,David Jayne,Cees G. M. Kallenberg,Peter Lamprecht,Carol A. Langford,Raashid Luqmani,Alfred Mahr,Eric L. Matteson,Peter A. Merkel,Peter A. Merkel,Seza Ozen,Charles D. Pusey,Niels Rasmussen,Andrew J. Rees,David G. I. Scott,Ulrich Specks,John H. Stone,Kei Takahashi,Richard A. Watts +28 more
TL;DR: 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides J. Watts; Arthritis & Rheumatism
Journal ArticleDOI
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
John H. Stone,Peter A. Merkel,Robert Spiera,Philip Seo,Carol A. Langford,Gary S. Hoffman,Cees G. M. Kallenberg,E. William St. Clair,Anthony M. Turkiewicz,Nadia K. Tchao,Lisa Webber,Linna Ding,Lourdes P. Sejismundo,Kathleen Mieras,David Weitzenkamp,David Ikle,Vicki Seyfert-Margolis,Mark Mueller,Paul Brunetta,Nancy B. Allen,Fernando C. Fervenza,Duvuru Geetha,Karina A. Keogh,Eugene Y. Kissin,Paul A. Monach,Tobias Peikert,Coen A. Stegeman,Steven R. Ytterberg,Ulrich Specks +28 more
TL;DR: Rituximab therapy was not inferior to daily cyclophosphamide treatment for induction of remission in severe ANCA-associated vasculitis and may be superior in relapsing disease.
Journal ArticleDOI
EULAR Recommendations for the management of primary small and medium vessel vasculitis
Chetan Mukhtyar,Loïc Guillevin,Maria C. Cid,Bhaskar Dasgupta,K de Groot,Wolfgang L. Gross,Thomas H. Hauser,B Hellmich,David Jayne,Cees G. M. Kallenberg,Peter A. Merkel,Heiner Raspe,Carlo Salvarani,Dgi Scott,Coen A. Stegeman,Richard A. Watts,Kerstin Westman,James Witter,Halil Yazici,Raashid Luqmani +19 more
TL;DR: On the basis of evidence and expert consensus, recommendations have been made for the evaluation, investigation, treatment and monitoring of patients with small and medium vessel vasculitis for use in everyday clinical practice.
Journal ArticleDOI
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
George Bertsias,John P. A. Ioannidis,John Boletis,Stefano Bombardieri,Ricard Cervera,C. Dostal,J Font,Inge-Magrethe Gilboe,F. Houssiau,Twj Huizinga,David A. Isenberg,Cees G. M. Kallenberg,Munther A. Khamashta,J.C. Piette,Matthias Schneider,Matthias Schneider,Josef S Smolen,Gunnar Sturfelt,Angela Tincani,R. van Vollenhoven,Caroline Gordon,Dimitrios T. Boumpas +21 more
TL;DR: Recommendations for the management of SLE were developed using an evidence-based approach followed by expert consensus with high level of agreement among the experts.
Journal ArticleDOI
EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases
S. van Assen,Nancy Agmon-Levin,Ori Elkayam,Ricard Cervera,Michele F. Doran,Maxime Dougados,Paul Emery,Paul Emery,Pierre Geborek,John P. A. Ioannidis,David Jayne,Cees G. M. Kallenberg,Ulf Müller-Ladner,Yehuda Shoenfeld,Yehuda Shoenfeld,Ljudmila Stojanovich,Guido Valesini,NM Wulffraat,Marc Bijl +18 more
TL;DR: Recommendations for vaccination in patients with AIIRD based on the currently available evidence and expert opinion were formulated, and more research is needed, particularly regarding the incidence of vaccine-preventable infectious diseases and the safety of vaccination in Patients with A IIRD.